Displaying 2601 - 2620 of 38636
September 8, 2023
Case Timeline Item
Intuit Inc., In the Matter of (TurboTax) (timeline item) - September 8, 2023
Date
File
Initial Decision
(11.21 MB)
September 7, 2023
FTC Announces Tentative Agenda for September 14 Open Meeting
Date
Today, Federal Trade Commission Chair Lina M. Khan announced that an open meeting of the Commission will be held virtually on Thursday, September 14, 2023. The open meeting will commence at 11 a.m. ET...
FTC Finalizes Order with 1Health.io Over Charges it Failed to Protect Privacy and Security of DNA Data and Unfairly Changed its Privacy Policy
Date
The Federal Trade Commission finalized an order with 1Health.io that settles charges that the genetic testing firm left sensitive genetic and health data unsecured, deceived consumers about their...
Case Timeline Item
1Health.io/Vitagene, In the Matter of (timeline item) - September 7, 2023
Date
File
Complaint
(924.81 KB)
File
Decision and Order
(245.53 KB)
File
Letter to Commenters
(324.02 KB)
September 6, 2023
FTC to Host Funeral Rule Workshop on September 7
Date
WHAT: The Federal Trade Commission will host hybrid panel discussions in person and online with a diverse set of experts to explore several issues related to the Funeral Rule, including whether and...
September 5, 2023
Case Timeline Item
IQVIA Holdings/Propel Media, In the Matter of (timeline item) - September 5, 2023
Date
File
Notice of Appearance - V. Siva
(865.35 KB)
File
Notice of Appearance - C. Lamar
(942.6 KB)
September 1, 2023
Statement of Chair Lina M. Khan Joined By Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya In the Matter of Amgen, Inc. and Horizon Therapeutics plc
Date
By
Lina M. Khan, Former Chair and Commissioner;
Alvaro Bedoya, Former Commissioner;
Rebecca Kelly Slaughter, Former Commissioner
Biopharmaceutical Giant Amgen to Settle FTC and State Challenges to its Horizon Therapeutics Acquisition
Date
The Federal Trade Commission reached a proposed consent order with Amgen Inc. to address the potential competitive harm that would result from Amgen’s $27.8 billion acquisition of Horizon Therapeutics...
FTC and DOJ to Co-Host 2023 Draft Merger Guidelines Workshop on September 5
Date
WHAT: The Federal Trade Commission and Justice Department are co-hosting a workshop to facilitate public dialogue on the 2023 Draft Merger Guidelines . WHEN: Tuesday, September 5, 2023, 1 p.m. – 4:15...
Case Timeline Item
Amgen, Inc. and Horizon Therapeutics plc, In the Matter of (timeline item) - September 1, 2023
Date
File
Agreement Containing Consent Order
(1.67 MB)
File
Decision and Order (Public Version)
(5.43 MB)
File
Analysis to Aid Public Comment
(3.72 MB)
August 31, 2023
FTC Secures Settlement with ICE and Black Knight Resolving Antitrust Concerns in Mortgage Technology Deal
Date
The Federal Trade Commission today approved a proposed consent order to resolve antitrust concerns surrounding Intercontinental Exchange, Inc.’s (ICE) proposed $13.1 billion acquisition of Black...
Case Timeline Item
Intercontinental Exchange, Inc./Black Knight, Inc., In the Matter of (timeline item) - August 31, 2023
Date
File
Agreement Containing Consent Orders
(168.88 KB)
File
Order to Maintain Assets
(205.3 KB)
File
Decision and Order
(394.82 KB)
August 30, 2023
Case Timeline Item
Credit Bureau Center, LLC (formerly known as MyScore LLC) (timeline item) - August 30, 2023
Date
File
August 29, 2023
FTC Finalizes Order Against Clothing Accessories Company for False Made in USA Claims
Date
The Federal Trade Commission has finalized its order against a group of Massachusetts- and New Hampshire-based clothing accessories companies, along with their owner, Thomas Bates, for falsely...
Displaying 2601 - 2620 of 38636